跳至主要内容
临床试验/EUCTR2009-012609-20-IT
EUCTR2009-012609-20-IT进行中(未招募)不适用

INTRAVITREAL BEVACIZUMAB INJECTION VS. CONVENTIONAL LASER SURGERY FOR VISION-THREATENING RETINOPATHY OF PREMATURITY. - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2009年5月27日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • preterm newborns EG less or equal to 29 weeks and/or birth weigth less or equal to mg with AP-ROP
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Congenital malformation or different ROP staging between the to eyes

研究者

发起方
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

相似试验

INTRAVITREAL BEVACIZUMAB INJECTION VS. CONVENTIONAL... | 临床试验